{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:00:01Z","timestamp":1780380001563,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T00:00:00Z","timestamp":1334102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2334-12-86","type":"journal-article","created":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T14:14:44Z","timestamp":1334153684000},"source":"Crossref","is-referenced-by-count":72,"title":["The high comorbidity burden of the hepatitis C virus infected population in the United States"],"prefix":"10.1186","volume":"12","author":[{"given":"Karly S","family":"Louie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"St Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla M","family":"Forssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M","family":"Mundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne M","family":"Pimenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,11]]},"reference":[{"key":"1764_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","volume":"144","author":"GL Armstrong","year":"2006","unstructured":"Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ: The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006, 144: 705-714.","journal-title":"Ann Intern Med"},{"key":"1764_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB: Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009, 49: 1335-1374. 10.1002\/hep.22759.","journal-title":"Hepatology"},{"key":"1764_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1053\/jlts.2003.50073","volume":"9","author":"GL Davis","year":"2003","unstructured":"Davis GL, Albright JE, Cook SF, Rosenberg DM: Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 2003, 9: 331-338. 10.1053\/jlts.2003.50073.","journal-title":"Liver Transpl"},{"issue":"Suppl 1","key":"1764_CR4","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1002\/hep.1840360705","volume":"36","author":"WR Kim","year":"2002","unstructured":"Kim WR: The burden of hepatitis C in the United States. Hepatology. 2002, 36 (Suppl 1): S30-S34.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"1764_CR5","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.jhep.2005.11.009","volume":"44","author":"J Massard","year":"2006","unstructured":"Massard J, Ratziu V, Thabut D, Moussalli J, Lebray P, Benhamou Y, et al: Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol. 2006, 44 (Suppl 1): S19-S24.","journal-title":"J Hepatol"},{"key":"1764_CR6","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/hep.24641","volume":"54","author":"MG Ghany","year":"2011","unstructured":"Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB: An update on treatment of genotype 1 chronic hepatitis c virus infection: 2011 Practice guideline by the american association for the study of liver diseases. Hepatology. 2011, 54: 1433-1444. 10.1002\/hep.24641.","journal-title":"Hepatology"},{"key":"1764_CR7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/hep.20119","volume":"39","author":"DB Strader","year":"2004","unstructured":"Strader DB, Wright T, Thomas DL, Seeff LB: Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004, 39: 1147-1171. 10.1002\/hep.20119.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"1764_CR8","doi-asserted-by":"publisher","first-page":"S237","DOI":"10.1002\/hep.1840360730","volume":"36","author":"MW Fried","year":"2002","unstructured":"Fried MW: Side effects of therapy of hepatitis C and their management. Hepatology. 2002, 36 (Suppl 1): S237-S244.","journal-title":"Hepatology"},{"key":"1764_CR9","unstructured":"Elixhauser A, Palmer L: Clinical Classification Softward (CCS), 2006. US Agency for Healthcare Reseach and Quality. [ http:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/ccs_svcsproc\/ccssvcproc.jsp ]"},{"key":"1764_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/0021-9681(70)90054-8","volume":"23","author":"AR Feinstein","year":"1970","unstructured":"Feinstein AR: The pre-therapeutic classification of co-morbidity in chronic disease. J Chroni Dis. 1970, 23: 455-468. 10.1016\/0021-9681(70)90054-8.","journal-title":"J Chroni Dis"},{"key":"1764_CR11","unstructured":"Centers for Disease and Control and Prevention: FAQs for the public. Centers for Disease and Control and Prevention 2010. [cited 2010 May 2], [ http:\/\/www.cdc.gov\/hepatitis\/C\/cFAQ.htm#cFAQ15 ]"},{"key":"1764_CR12","first-page":"1","volume":"19","author":"NIH","year":"2002","unstructured":"NIH: NIH consensus statement on management of Hepatitis C. NIH Consens State Sci Statements. 2002, 19: 1-46.","journal-title":"NIH Consens State Sci Statements"},{"key":"1764_CR13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.dld.2007.01.009","volume":"39","author":"G Parrilli","year":"2007","unstructured":"Parrilli G, Manguso F, Orsini L, Coccoli P, Vecchione R, Terracciano L, De Luca N, Cirillo N, Abazia C, Budillon G, Marchesini G: Essential hypertension and chronic viral hepatitis. Dig Liver Dis. 2007, 39: 466-472. 10.1016\/j.dld.2007.01.009.","journal-title":"Dig Liver Dis"},{"key":"1764_CR14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1365-2893.2007.00885.x","volume":"14","author":"AA Butt","year":"2007","unstructured":"Butt AA, Khan UA, McGinnis KA, Skanderson M, Kent KC: Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans. J Viral Hepat. 2007, 14: 890-896.","journal-title":"J Viral Hepat"},{"key":"1764_CR15","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/DAD.0b013e31819d095e","volume":"31","author":"M Magana","year":"2009","unstructured":"Magana M, Gomez LM: Skin metastasis from hepatocarcinoma. Am J Dermatopathol. 2009, 31: 502-505. 10.1097\/DAD.0b013e31819d095e.","journal-title":"Am J Dermatopathol"},{"key":"1764_CR16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/014556130808700912","volume":"87","author":"WR Reisacher","year":"2008","unstructured":"Reisacher WR: Prevalence of autoimmune thyroid disease in chronic rhinitis. Ear Nose Throat J. 2008, 87: 524-527.","journal-title":"Ear Nose Throat J"},{"key":"1764_CR17","unstructured":"Hoffman-La Roche Inc: Medication Guide: Pegasys (peg-interferon alfa-2a), 2008. Accessed 10 July 2010, [ http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/ucm088679.pdf ]"},{"key":"1764_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tem.2009.07.005","volume":"21","author":"GH Syed","year":"2010","unstructured":"Syed GH, Amako Y, Siddiqui A: Hepatitis C virus hijacks host lipid metabolism. Trends Endocrinol Metab. 2010, 21: 33-40. 10.1016\/j.tem.2009.07.005.","journal-title":"Trends Endocrinol Metab"},{"key":"1764_CR19","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/ajg.2009.191","volume":"104","author":"G Garcia-Tsao","year":"2009","unstructured":"Garcia-Tsao G, Lim JK: Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009, 104: 1802-1829. 10.1038\/ajg.2009.191.","journal-title":"Am J Gastroenterol"},{"key":"1764_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1542-3565(04)00666-4","volume":"3","author":"RG Gish","year":"2005","unstructured":"Gish RG, Afdhal NH, Dieterich DT, Reddy KR: Management of hepatitis C virus in special populations: patient and treatment considerations. Clin Gastroenterol Hepatol. 2005, 3: 311-318. 10.1016\/S1542-3565(04)00666-4.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1764_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1365-2893.2005.00607.x","volume":"12","author":"JS Markowitz","year":"2005","unstructured":"Markowitz JS, Gutterman EM, Hodes D, Klaskala W: Factors associated with the initiation of alpha-interferon treatment in Medicaid patients diagnosed with hepatitis C. J Viral Hepat. 2005, 12: 176-185. 10.1111\/j.1365-2893.2005.00607.x.","journal-title":"J Viral Hepat"},{"key":"1764_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/00004836-200203000-00015","volume":"34","author":"AJ Muir","year":"2002","unstructured":"Muir AJ, Provenzale D: A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection. J Clin Gastroenterol. 2002, 34: 268-271. 10.1097\/00004836-200203000-00015.","journal-title":"J Clin Gastroenterol"},{"key":"1764_CR23","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1111\/j.1572-0241.2007.01433_4.x","volume":"102","author":"ML Schiffman","year":"2007","unstructured":"Schiffman ML: A balancing view: we cannot do it alone. Am J Gastroenterol. 2007, 102: 1841-1843. 10.1111\/j.1572-0241.2007.01433_4.x.","journal-title":"Am J Gastroenterol"},{"key":"1764_CR24","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1002\/hep.23220","volume":"50","author":"ML Volk","year":"2009","unstructured":"Volk ML, Tocco R, Saini S, Lok AS: Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology. 2009, 50: 1750-1755. 10.1002\/hep.23220.","journal-title":"Hepatology"},{"key":"1764_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJM200107193450312","volume":"345","author":"GL Davis","year":"2001","unstructured":"Davis GL, Rodrigue JR: Treatment of chronic hepatitis C in active drug users. N Engl J Med. 2001, 345: 215-217. 10.1056\/NEJM200107193450312.","journal-title":"N Engl J Med"},{"key":"1764_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1086\/600304","volume":"49","author":"M Hellard","year":"2009","unstructured":"Hellard M, Sacks-Davis R, Gold J: Hepatitis C treatment for injection drug users: a review of the available evidence. Clin Infect Dis. 2009, 49: 561-573. 10.1086\/600304.","journal-title":"Clin Infect Dis"},{"key":"1764_CR27","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1148\/radiology.216.3.r00se24698","volume":"216","author":"S Katyal","year":"2000","unstructured":"Katyal S, Oliver JH, Peterson MS, Ferris JV, Carr BS, Baron RL: Extrahepatic metastases of hepatocellular carcinoma. Radiology. 2000, 216: 698-703.","journal-title":"Radiology"},{"key":"1764_CR28","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/hep.1840360621","volume":"36","author":"HB El Serag","year":"2002","unstructured":"El Serag HB, Hampel H, Yeh C, Rabeneck L: Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 2002, 36: 1439-1445.","journal-title":"Hepatology"},{"key":"1764_CR29","first-page":"813","volume":"21","author":"F Fabrizi","year":"2008","unstructured":"Fabrizi F, Lunghi G, Messa P, Martin P: Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol. 2008, 21: 813-825.","journal-title":"J Nephrol"},{"key":"1764_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-2893.2010.01402.x","volume":"18","author":"AJ Muir","year":"2011","unstructured":"Muir AJ, Hu KQ, Gordon SC, Koury K, Boparai N, Noviello S, Albrecht JK, Sulkowski MS, McCone J: Hepatitis C treatment among racial and ethnic groups in the IDEAL trial. J Viral Hepat. 2011, 18: 134-143. 10.1111\/j.1365-2893.2010.01402.x.","journal-title":"J Viral Hepat"},{"key":"1764_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/hep.24131","volume":"53","author":"M Stepanova","year":"2011","unstructured":"Stepanova M, Kanwal F, El-Serag HB, Younossi ZM: Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States. Hepatology. 2011, 53: 737-745. 10.1002\/hep.24131.","journal-title":"Hepatology"},{"key":"1764_CR32","volume-title":"AIDS Res Hum Retroviruses","author":"AA Butt","year":"2011","unstructured":"Butt AA, McGinnis K, Skanderson M, Justice AC: A Comparison of Treatment Eligibility for Hepatitis C Virus in HCV-Monoinfected versus HCV\/HIV-Coinfected Persons in Electronically Retrieved Cohort of HCV-Infected Veterans. AIDS Res Hum Retroviruses. 2011,"},{"key":"1764_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1478-3231.2009.02156.x","volume":"30","author":"AA Butt","year":"2010","unstructured":"Butt AA, McGinnis KA, Skanderson M, Justice AC: Hepatitis C treatment completion rates in routine clinical care. Liver Int. 2010, 30: 240-250. 10.1111\/j.1478-3231.2009.02156.x.","journal-title":"Liver Int"},{"key":"1764_CR34","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1097\/MCG.0b013e3181574d58","volume":"42","author":"AA Butt","year":"2008","unstructured":"Butt AA, Khan UA, Skanderson M: Comorbidities and their impact on mortality in HCV and HCV-HIV-coinfected persons on dialysis. J Clin Gastroenterol. 2008, 42: 1054-1059. 10.1097\/MCG.0b013e3181574d58.","journal-title":"J Clin Gastroenterol"},{"key":"1764_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/01.mcg.0000225629.22286.96","volume":"41","author":"AW Dollarhide","year":"2007","unstructured":"Dollarhide AW, Loh C, Leckband SG, Endow-Eyer R, Robinson S, Meyer JM: Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans. J Clin Gastroenterol. 2007, 41: 322-328. 10.1097\/01.mcg.0000225629.22286.96.","journal-title":"J Clin Gastroenterol"},{"key":"1764_CR36","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1360-0443.2006.01698.x","volume":"102","author":"V Guadagnino","year":"2007","unstructured":"Guadagnino V, Trotta MP, Montesano F, Babudieri S, Caroleo B, Armignacco O, Carioti J, Maio G, Monarca R, Antinori A, Nocchiero Study Group: Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes. Addiction. 2007, 102: 423-431. 10.1111\/j.1360-0443.2006.01698.x.","journal-title":"Addiction"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-86\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-86.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-86","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-86.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T02:50:22Z","timestamp":1713840622000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-86"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,11]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1764"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-86","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,11]]},"article-number":"86"}}